BRCA1 and breast carcinoma: TNBC is characterized biologically by having a histopathological similarity with germline BRCA1-mutated breast cancer (BRCA-ness phenotype) [11–14] with 90% of BRCA1-mutation tumors being considered as TNBC [15].